Alzheimer’s Disease (AD) is a worldwide problem that does not yet have a clear solution. Although new treatments are starting to emerge, they do not work for every patient. The reason is likely individual difference in the specific, molecular, causes of AD. In our project, we will explore an innovative method to classify AD patients and guide personalized treatment selection and treatment development. We hope this custom approach allows successfully treating more AD cases.
Biotech Booster connects Business Developers and the newly introduced Impact Developers to the broader ecosystem. While both roles focus on
Biotech Booster connects Business Developers and the newly introduced Impact Developers to the broader ecosystem. While both roles focus on
‘Nieuwe precisietherapie van biotechbedrijf Lumox moet tumoren gericht vernietigen en ingrijpende operaties helpen voorkomen’ Kankercellen doden met licht. Klinkt dat
Yerseke, Zeeland – 14 juli 2026 Op 13 juli was de commissaris van de Koning in Zeeland Hugo de Jonge
Biotech Booster connects Business Developers and the newly introduced Impact Developers to the broader ecosystem. While both roles focus on
Food security and climate change are reshaping the future of agriculture. As farmland becomes scarcer and weather conditions more unpredictable,
Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.
Constellate
What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.
ProteoT
Receive monthly updates about our community!
